Gao X, Ding J, Xie J, Xu H
Acta Pharmacol Sin. 2025; .
PMID: 40069488
DOI: 10.1038/s41401-025-01499-6.
Harvey J, Smith A, Weymouth L, Smith R, Castanho I, Hubbard L
NPJ Parkinsons Dis. 2025; 11(1):39.
PMID: 40025048
PMC: 11873129.
DOI: 10.1038/s41531-025-00877-5.
Al-Qahtani Z, Alqahtani A, Alzuhairi A, Qarah M, Alqarni A, Alqahtani A
Neuropsychiatr Dis Treat. 2025; 21:241-256.
PMID: 39926117
PMC: 11806747.
DOI: 10.2147/NDT.S493629.
Harada Y, Iwabe T, Ota K, Hamada S, Moriwaka F
Phys Ther Res. 2025; 27(3):173-179.
PMID: 39866393
PMC: 11756565.
DOI: 10.1298/ptr.E10290.
Chabbouh A, Khalil H, Abboud C, Sader A, Khoury R
J Int Med Res. 2024; 52(12):3000605241304646.
PMID: 39687936
PMC: 11653321.
DOI: 10.1177/03000605241304646.
Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson's disease: A French survey.
Barre T, Cazorla G, Di Beo V, Lopez F, Radoszycki L, Maradan G
Clin Park Relat Disord. 2024; 11:100286.
PMID: 39687323
PMC: 11647636.
DOI: 10.1016/j.prdoa.2024.100286.
Psycho-physical interactions in Parkinson's Disease: Protocol for a prospective observational cohort study.
Hodgson P, Jordan A, Sinani C, Charura D
PLoS One. 2024; 19(12):e0315345.
PMID: 39680551
PMC: 11649133.
DOI: 10.1371/journal.pone.0315345.
Efficacy of acupuncture in ameliorating anxiety in Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis.
Wu Z, Liu C, Chan V, Wu X, Huang F, Guo Z
Front Aging Neurosci. 2024; 16:1462851.
PMID: 39588511
PMC: 11586373.
DOI: 10.3389/fnagi.2024.1462851.
Breaking barriers in Parkinson's care: the multidisciplinary team approach.
Pirtosek Z
J Neural Transm (Vienna). 2024; 131(11):1349-1361.
PMID: 39417880
PMC: 11502601.
DOI: 10.1007/s00702-024-02843-6.
Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians.
Ip C, Kassubek J, Storch A, Tonges L, Wolz M, Jost W
J Neural Transm (Vienna). 2024; 131(10):1263-1273.
PMID: 39370478
DOI: 10.1007/s00702-024-02838-3.
Parkinson's LRRK2-G2019S risk gene mutation drives sex-specific behavioral and cellular adaptations to chronic variable stress.
Guevara C, Alloo K, Gupta S, Thomas R, Del Valle P, Magee A
Front Behav Neurosci. 2024; 18:1445184.
PMID: 39328984
PMC: 11425082.
DOI: 10.3389/fnbeh.2024.1445184.
Estimating the prevalence, factors, and conditions associated with Parkinson disease: a population-based study in Peru.
Bernabe-Ortiz A, Carrillo-Larco R
Cad Saude Publica. 2024; 40(9):e00011324.
PMID: 39319944
PMC: 11415045.
DOI: 10.1590/0102-311XEN011324.
Cognitive behavioral therapy approaches to the improvement of mental health in Parkinson's disease patients: a systematic review and meta-analysis.
Wu X, Shi M, Lian Y, Zhang H
BMC Neurol. 2024; 24(1):352.
PMID: 39300337
PMC: 11411832.
DOI: 10.1186/s12883-024-03859-x.
Psychological Factors Affecting Assertiveness in Subjects with Parkinson's Disease.
Lo Buono V, Culicetto L, Berenati M, Stroscio G, Sorbera C, Brigandi A
J Clin Med. 2024; 13(16).
PMID: 39200767
PMC: 11354411.
DOI: 10.3390/jcm13164625.
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease.
Soares N, da Silva P, Pereira G, Leoni R, Mello Rieder C, Alva T
Neuroradiology. 2024; 66(11):1955-1966.
PMID: 39190159
DOI: 10.1007/s00234-024-03452-6.
Influence of Depression on the Quality of Life in Patients With Parkinson's Disease in Southwest Nigeria.
Orji O, Ijioma C, Odarah J, Okeji I, Areh J, Anele D
Cureus. 2024; 16(7):e65077.
PMID: 39171038
PMC: 11337142.
DOI: 10.7759/cureus.65077.
Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort.
Chen X, He C, Ma J, Yang R, Qi Q, Gao Z
CNS Neurosci Ther. 2024; 30(8):e14918.
PMID: 39129413
PMC: 11317696.
DOI: 10.1111/cns.14918.
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.
Kalbe E, Folkerts A, Witt K, Buhmann C, Liepelt-Scarfone I
J Neurol. 2024; 271(11):7330-7357.
PMID: 39120709
PMC: 11561078.
DOI: 10.1007/s00415-024-12503-0.
Stress perception and associated factors among patients with Parkinson's disease: a cross-sectional study after the COVID-19 pandemic.
Pan Y, Liang D, Lu L, Yu Z, Wang B, Luo W
BMC Psychiatry. 2024; 24(1):522.
PMID: 39044198
PMC: 11264369.
DOI: 10.1186/s12888-024-05972-0.
Facial emotion recognition and judgment of affective scenes in Parkinson's disease.
Salfi F, Toro S, Saporito G, Sucapane P, Marano M, Montaruli G
Heliyon. 2024; 10(12):e32947.
PMID: 38975139
PMC: 11226888.
DOI: 10.1016/j.heliyon.2024.e32947.